BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 26418443)

  • 1. CENTRAL SEROUS CHORIORETINOPATHY: High-Resolution Imaging of Asymptomatic Fellow Eyes Using Adaptive Optics Scanning Laser Ophthalmoscopy.
    Gerardy M; Yesilirmak N; Legras R; Behar-Cohen F; Bousquet E
    Retina; 2022 Feb; 42(2):375-380. PubMed ID: 34620798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASSESSING PHOTORECEPTOR STRUCTURE ASSOCIATED WITH ELLIPSOID ZONE DISRUPTIONS VISUALIZED WITH OPTICAL COHERENCE TOMOGRAPHY.
    Scoles D; Flatter JA; Cooper RF; Langlo CS; Robison S; Neitz M; Weinberg DV; Pennesi ME; Han DP; Dubra A; Carroll J
    Retina; 2016 Jan; 36(1):91-103. PubMed ID: 26166796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY (FLIO) PATTERNS IN CLINICALLY UNAFFECTED CHILDREN OF MACULAR TELANGIECTASIA TYPE 2 (MACTEL) PATIENTS.
    Sauer L; Vitale AS; Andersen KM; Hart B; Bernstein PS
    Retina; 2020 Apr; 40(4):695-704. PubMed ID: 31517727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-stage macular telangiectasia type 2 vascular abnormalities are associated with interdigitation zone disruption.
    Ong JX; Zandi R; Fawzi AA
    PLoS One; 2021; 16(11):e0259811. PubMed ID: 34767582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative Ellipsoid Zone Reflectivity in Macular Telangiectasia Type 2.
    Goerdt L; Weinhold L; Isselmann B; Garcia JLR; Künzel SH; Schmid M; Holz FG; Tzaridis S; Thiele S
    Invest Ophthalmol Vis Sci; 2023 Jul; 64(10):21. PubMed ID: 37462978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2 WITH AND WITHOUT DIABETES.
    Sauer L; Vitale AS; Jacoby RS; Hart B; Bernstein PS
    Retina; 2023 Sep; 43(9):1597-1607. PubMed ID: 37263186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling the mysteries of macular telangiectasia 2: the intersection of philanthropy, multimodal imaging and molecular genetics. The 2022 founders lecture of the pan American vitreoretinal society.
    Wu L
    Int J Retina Vitreous; 2023 Nov; 9(1):69. PubMed ID: 37968753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of photoreceptor features in retinitis pigmentosa with cystoid macular edema by using an adaptive optics fundus camera.
    Kitahata S; Gocho K; Motozawa N; Yokota S; Yamamoto M; Maeda A; Hirami Y; Kurimoto Y; Kadonosono K; Takahashi M
    PLoS One; 2024; 19(1):e0296493. PubMed ID: 38166083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Type 2 Macular Telangiectasia a Bilateral and Symmetrical Disease Entity?
    Venkatesh R; Nahata H; Reddy NG; Mishra P; Mangla R; Yadav NK; Chhablani J
    J Curr Ophthalmol; 2022; 34(4):428-435. PubMed ID: 37180535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced foveal cone density in early idiopathic macular telangiectasia.
    Song H; Rossi EA; Williams DR
    BMJ Open Ophthalmol; 2021; 6(1):e000603. PubMed ID: 33490602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-Time Imaging of Retinal Ganglion Cell Apoptosis.
    Yap TE; Donna P; Almonte MT; Cordeiro MF
    Cells; 2018 Jun; 7(6):. PubMed ID: 29914056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photoreceptor-Based Biomarkers in AOSLO Retinal Imaging.
    Litts KM; Cooper RF; Duncan JL; Carroll J
    Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO255-BIO267. PubMed ID: 28873135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LONGITUDINAL CORRELATION OF ELLIPSOID ZONE LOSS AND FUNCTIONAL LOSS IN MACULAR TELANGIECTASIA TYPE 2.
    Heeren TFC; Kitka D; Florea D; Clemons TE; Chew EY; Bird AC; Pauleikhoff D; Charbel Issa P; Holz FG; Peto T
    Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S20-S26. PubMed ID: 28541959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fundus photo has met its match: optical coherence tomography and adaptive optics ophthalmoscopy are here to stay.
    Morgan JI
    Ophthalmic Physiol Opt; 2016 May; 36(3):218-39. PubMed ID: 27112222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CONE DENSITY LOSS ON ADAPTIVE OPTICS IN EARLY MACULAR TELANGIECTASIA TYPE 2.
    Jacob J; Krivosic V; Paques M; Tadayoni R; Gaudric A
    Retina; 2016 Mar; 36(3):545-51. PubMed ID: 26418443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Takayama K; Arakawa N; Tsujikawa A; Koizumi H; Oshima S; Yoshimura N
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5541-50. PubMed ID: 21642620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cone pathologic changes in idiopathic macular telangiectasia types 1 and 2 using adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Takayama K; Ueda-Arakawa N; Tsujikawa A; Yamashiro K; Oishi A; Hanebuchi M; Yoshimura N
    Am J Ophthalmol; 2013 Jun; 155(6):1045-1057.e4. PubMed ID: 23465268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Sakamoto A; Tsujikawa A; Yamashiro K; Ojima Y; Yamada Y; Mukai H; Oshima S; Inoue T; Yoshimura N
    Ophthalmology; 2010 Sep; 117(9):1800-9, 1809.e1-2. PubMed ID: 20673590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MACULAR TELANGIECTASIA TYPE 2 IN AN OTHERWISE HEALTHY TEENAGE BOY WITH CONSANGUINEOUS PARENTS.
    Ryu CL; Mikhail M; Khan A; Chen JC; Omar A
    Retin Cases Brief Rep; 2018 Summer; 12(3):200-203. PubMed ID: 27828905
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.